Lupin 2024

metformin hydrochloride extended-release tablets USP

Glenmark receives ANDA approval for metformin hydrochloride extended-release tablets

Glenmark receives ANDA approval for metformin hydrochloride extended-release tablets

MUMBAI, India — Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for metformin hydrochloride extended-release tablets USP, 500 mg and 1000 mg, the generic version of Glumetza Extended-Release Tablets, 500 mg and 1000 mg, of Salix Pharmaceuticals Inc. According to IQVIA sales data for the 12-month

Centrum 7/6  banner